The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?-Reference-Cited by-同舟云学术

The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?

Published:2020-12 Issue:6 Volume:18 Page:e698-e704
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Roscigno Marco,Stabile Armando,Lughezzani Giovanni,Pepe Pietro,Galosi Andrea Benedetto,Naselli Angelo,Naspro Richard,Nicolai Maria,La Croce Giovanni,Aljoulani Muhannad,Perugini Giovanna,Guazzoni Giorgio,Montorsi Francesco,Balzarini Luca,Sironi Sandro,Da Pozzo Luigi Filippo

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference20 articles.

1. Active surveillance for the management of localized prostate cancer: guideline recommendations;Morash;Can Urol Assoc J,2015

2. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer;Suardi;BJU Int,2010

3. The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy;Lee;Eur Urol,2010

4. Active surveillance for prostate cancer: a narrative review of clinical guidelines;Bruinsma;Nat Rev Urol,2016

5. Systematic review of complications of prostate biopsy;Loeb;Eur Urol,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China;World Journal of Surgical Oncology;2024-05-28

2. Diagnostic value comparison of the combination of prostate-specific membrane antigen-body PET/MR and the prostate health index with each alone in early diagnosis of prostate cancer;Asian Journal of Urology;2024-02

3. Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution;BJU International;2024-01-22

4. Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance;In Vivo;2024

5. Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions;Technology in Cancer Research & Treatment;2024-01